s6y
Company name or ticker
Search
Column Group Management LP
4
NGM BIOPHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
Filed
Wednesday, May 11, 2022
Period
May 9, 2022
Accession number
0000899243-22-017672
Documents
FORM 4 SUBMISSION
4
On sec.gov
Filing index
All files
Complete submission text
SGML header